How Bad is my Batch

COVID-19 patients show more signs of brain damage than people with Alzheimer’s disease.

“How Bad is My Batch”? Check It Out Now – Europe Reloaded

“How Bad is my Batch”? Check It Out Now
January 14, 2022TLB Staff COMMENTARYHEALTHTyranny

Exclusive: Have 100% of US Covid-19 Vaccine Deaths Been Caused by Just 5% of the Batches?
Find Dr. Robert Malone on Substack: Robert W Malone MD, MS on Substack

The story of my vaccine injury:
By DR. ROBERT MALONE, M.D.

The second shot almost did me in. As in, I almost died.
After the injection, I had the usual fatigue, muscle-ache and then the palpitations started, as well as shortness of breath. Within a couple days, it got worse – I am not someone who goes to the doctor easily, but luckily for me, I happened to have a routine appointment with my physician. She cuffed me and my systolic blood pressure was through the roof. As she is also a cardiologist, she had more tests run, started me on high blood pressure meds and we got it under control. I kind of feel like I owe her my life.

A call out to the fantastic Dr. C. Bove. Fast forward to today.
One of the people who comments on my Sub stack articles, pointed me to this website:
https://www.howbadismybatch.com/

This site matches up vaccine batch codes with information from the VAERS system, which is the event reporting system run by the CDC. This site matches the vaccine batches to adverse drug reactions, death, disability and life-threatening illnesses from the VAERS system.

According to the website above, the data reported in VAERS, reproduced on the site, show that adverse events triggered by Moderna batches have varied widely.

5% of the batches appear to have produced 90% of the adverse reactions
Some Moderna batches are associated with 50 x the number of deaths and disabilities compared to other batches.
With that knowledge, I entered my batch code in the search box. The first injection had almost no significant adverse events associated with it. The second jab, frankly, shocked me.

Here are the results:

Now, I don’t know how many doses are in each batch. But I do know my batch was most definitely in the top 5%. So, not really a surprise in retrospect that I had such a serious adverse event profile.
I always felt I was lucky that I happened to be going to my physician that day, who is also a cardiologist (she is my internist – so I wasn’t seeing her for that specialty).
But just think- our government had this data way back when in the VAERs system -even last summer. This data is so compelling and yet…crickets. How many people could they have helped by releasing this data? People like me, who if I wasn’t a physician and hadn’t gone to my physician could have easily dropped dead.
What is wrong with our government that a site like this is not available from the CDC or the FDA?
If anyone has any doubts about adverse events from these vaccines, take a look at some
of the peer reviewed research or look at the VAERS data for deaths in young adults and children.
People have the right to be given informed consent of risks and benefits of a medical procedure. Informed consent is not given, if the risks are hidden.

WHERE THERE IS RISK, THERE MUST BE CHOICE!

************

COVID-19 patients show more signs of brain damage than people with Alzheimer’s disease. By Chris Melore

NEW YORK (StudyFinds.org) — Could COVID-19 actually be doing more harm to the human brain than Alzheimer’s disease? A new study reveals older patients contracting COVID have more signs of brain damage than people who develop the neurodegenerative disease.

Specifically, a team from NYU Grossman School of Medicine found significantly higher levels of certain blood proteins which typically rise when someone suffers neurological damage among COVID patients. Researchers say, over the short-term course of their infections, seven markers of brain damage were noticeably higher among COVID patients than non-COVID patients with Alzheimer’s. One of these markers was more than twice as high among coronavirus patients.

“Our findings suggest that patients hospitalized for COVID-19, especially in those with  neurological symptoms during their acute infection — may have levels of brain injury markers that are as high as, or higher than, those seen in people who have Alzheimer’s disease,” says lead author Jennifer Frontera, MD, a professor in the Department of Neurology, in a university release. Was it COVID, cold or flu? Here’s how you can tell  

Which blood markers should COVID patients worry about?
Study authors say the main sign of brain damage among the COVID patients was the condition toxic metabolic encephalopathy (TME). Symptoms range from confusion to coma, due to toxins created by the immune system reacting (sepsis), the kidneys failing, and not enough oxygen in the tissue.

The team examined 251 people hospitalized for COVID-19 during the first few months of the pandemic in 2020. The average age of the participants was 71 years-old, but all were in generally good health with no history of dementia or cognitive decline before their COVID infection. Researchers separated these patients into two groups, those with and without neurological symptoms due to COVID-19.

https://www.youtube.com/embed/3yOjz0UJyFw?autoplay=1
From there, the team compared these individuals to a group of control patients from the Clinical Core cohort of NYU Langone’s Alzheimer’s Disease Research Center. This group
is part of NYU’s long-term study of dementia and included 54 healthy people, 54 with mild cognitive decline, and 53 with Alzheimer’s disease. None of the control patients contracted COVID-19 during the study.

When it comes to what scientists were looking for, three blood markers – ubiquitin carboxy-terminal hydrolase L1 (UCHL1), total tau, and phosphorylated-tau-181 (ptau181) – all measure the death or disruption of neurons in the brain.
Levels of neurofilament light chain increase when the brain’s axons take damage.
These are branch-like extensions coming from the neurons. Glial fibrillary acidic protein (GFAP) levels measure the damage to glial cells, another type of brain cell that supports the neurons. Lastly, amyloid betas 40 and 42 are common markers which usually build up in people with Alzheimer’s.

Brain damage even worse among fatal COVID cases.

Results show the seven brain damage markers were over 60 percent higher 
among COVID patients with TME than those without the neurological symptoms. 
Concerningly, study authors found the markers for brain damage were even worse among patients that did not survive their coronavirus infection. Markers among patients who died from COVID were 124 percent higher than those who eventually left the hospital.
In comparison to patients with Alzheimer’s, results show markers for neurofilament light chain were 179 percent higher among coronavirus patients over the short-term. Levels of GFAP were also 65 percent higher among COVID patients in comparison to those with dementia.

“Traumatic brain injury, which is also associated with increases in these biomarkers,
does not mean that a patient will develop Alzheimer’s disease or related dementias later on, but does increase the risk of it,” says senior author Thomas Wisniewski, MD, director of the Center for Cognitive Neurology at NYU Langone. “Whether that kind of relationship exists in those who survive severe COVID-19 is a question we urgently need to answer with ongoing monitoring of these patients.” The study is published in the Alzheimer’s & Dementia®: The Journal of the Alzheimer’s Association.

‘Deltacron’: Should we worry about new COVID-19 variants merging?

Search Results for Covid 19 | Cancer Quick Facts (solitarius.org)

Virus Expert Just Issued This “Much Worse” Warning.

Covid 19 long term organ damage.

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload the CAPTCHA.